ZOJEMNI Trademark

Trademark Overview

On Thursday, April 12, 2018, a trademark application was filed for ZOJEMNI with the United States Patent and Trademark Office. The USPTO has given the ZOJEMNI trademark a serial number of 79232477. The federal status of this trademark filing is REGISTERED as of Tuesday, December 25, 2018. This trademark is owned by Merck KGaA. The ZOJEMNI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use in the field of oncology
zojemni

General Information

Serial Number79232477
Word MarkZOJEMNI
Filing DateThursday, April 12, 2018
Status700 - REGISTERED
Status DateTuesday, December 25, 2018
Registration Number5635263
Registration DateTuesday, December 25, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use in the field of oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 25, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type31 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Monday, December 25, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, April 26, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 10, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 10, 2019FINAL DISPOSITION PROCESSED
Monday, March 25, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 25, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Sunday, October 7, 2018NOTIFICATION PROCESSED BY IB
Wednesday, September 19, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 19, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 31, 2018REFUSAL PROCESSED BY IB
Wednesday, August 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 16, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 16, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 13, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 13, 2018REFUSAL PROCESSED BY MPU
Wednesday, August 1, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 31, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Tuesday, May 29, 2018APPLICATION FILING RECEIPT MAILED
Friday, May 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 24, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 24, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zojemni oncology field human preparations pharmaceutical